APR 07, 2016 10:17 AM PDT

New Computer Tool Tailors Drug Dosing for Patients

WRITTEN BY: Julianne Chiaet
This image represents a compilation of schematic, patient-specific, parabolic response surfaces, which are the keys to personalized medicine. They represent responses to combination therapy for individual patients for liver transplant immunosuppression.
How much medication should you be prescribed? Everyone is born with a different body, so how much and what kind of medication needs to be tailored to you. 

For instance, after a patient has received an organ transplant, they are at risk of their body rejecting the new organ. To combat this, doctors heavily treat the patient using immunosuppressive drugs. 
 
Immunosuppressive drugs have a narrow therapeutic range. If the dose is too high, it is toxic. If the dose is too low, it could fail to keep the body from rejecting the organ. Clinicians keep a close eye on their patients and make decisions about adjusting the dose according to how they are responding the drugs. They additionally decide whether the patient needs additional medications or therapies, such as dialysis. They ultimately consider a plethora of factors before deciding on their patient’s prescription regime.  

But, when it comes down to it, those “decisions” are actually educated guesses. Doctors can’t be 100 percent sure how a patient’s body will react. After all, a patient’s ethnicity, age, genetics, and comorbidity all affect how they respond to a medication. 
 

Now, a pilot study has demonstrated the effectiveness of a computational tool that could take the guesswork out of prescribing medications for immunosuppression, cancer, heart disease, bacterial infections, and other conditions that require tightly controlled treatment regimens. The research was published on April 6, 2016, in the journal Science Translational Medicine.

The tool, called parabolic personalized dosing (PPD), uses a mathematical approach to predict the next best dose of a drug for an individual. It harnesses a patient’s clinical data, such as the drug concentration in the bloodstream, to predict the next ideal dose per patient. PPD is different from other approaches based on mathematical modeling in that it uses an algebraic equation to build a parabolic map of the patient’s response to a drug. 

In the pilot trial, UCLA researchers treated four liver transplant patients with immunosuppressant drugs using doses determined by PPD. Another group was prescribed immunosuppressant drugs using standard physician-guided dosing. The patients guided by PPD stayed within the target drug dosing range more frequently than the latter group. The PPD patients also tended to have shorter hospital stays. 

The trial showed PPD also has the potential to optimize dosing for patients using a combination of drugs. The researchers hope clinicians will use PPD in the future to automatically tailor drug dosing for a wide range of patients, including those with cancer and heart disease. 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
JAN 15, 2020
Cardiology
JAN 15, 2020
Burnout May Cause Heart Problems
At least 2.7 million Americans are affected by the most common variety of irregular heartbeat, known as atrial fibrillation (AFib). Now, new research has f...
JAN 22, 2020
Clinical & Molecular DX
JAN 22, 2020
Biosignatures detect TB infections months before symptoms appear
What if there was a test that could detect tuberculosis six months before symptoms appear? Researchers at the University of College London think a predicti...
FEB 02, 2020
Genetics & Genomics
FEB 02, 2020
Ranking the Importance of Genes to Find Rare Disease-Causing Mutations
A team of scientists has classified genes according to how necessary they are for the survival of an organism....
FEB 07, 2020
Health & Medicine
FEB 07, 2020
Could False Cannabis Information Online Be Harmful To Public Health?
Under federal law, cannabis is illegal and considered a class 1 drug, meaning that it is perceived to have no medical value, with a high potential for user...
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 06, 2020
Technology
FEB 06, 2020
3D Skin Printer Promotes Healing
Researchers at the University of Toronto Engineering, Sunnybrook developed a new handheld 3D printer that can deposit sheets of skin to cover large burn wo...
Loading Comments...